Building a Biotech Investing Edge with Evan Markegard

In this episode of Mission Matters Money, host Adam Torres welcomes Evan Markegaard, founder and managing partner at AUGC Partners LLC, to discuss his unique approach to biotech investing. Evan shares his journey from earning a PhD in oncology at UCSF to launching a science-driven biotech hedge fund after working at Genentech. He emphasizes his competitive edge—combining deep scientific expertise, a focus on small-cap biotech companies in early clinical stages, and value investing principles inspired by Warren Buffett and Seth Klarman. Evan highlights how his background allows him to identify undervalued, innovative companies before larger players, particularly in areas like cancer therapeutics and novel drug modalities. He also reflects on the value of high-intensity networking events like iConnections Miami and the JP Morgan Healthcare Conference, which enable direct access to founders and emerging data. The conversation underscores the power of niche expertise, long-term thinking, and the transformative potential of biotech innovation for patients and investors alike.